What is notable is that expression of CD73, a novel immune checkpoint that promotes tumor progression by suppressing anti-tumor immune response and promoting angiogenesis (Chen S. et al., 2019), was significantly higher in 1p/19q codel LGG than 1p/19q non-codel LGGs. The gene discussed is NT5E; the disease is neoplasm.